Malin Corporation | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
Alaunos Therapeutics USD 1.01M 17K 2024-09
ALKERMES USD 146.99M 3.39M 2024-12
Avita Medical AUD 21.23M 2.57M 2024-12
Dianthus Therapeutics USD 6.54M 530K 2024-09
Eurofins Scientific SE 0 0 2023-06
Ionis Pharmaceuticals USD 88.08M 26.44M 2024-12
IQVIA Holdings USD 453M 69M 2024-12
Malin Corporation EUR 700K 1.6M 2024-06
Moderna USD 351M 70M 2024-12
Organon & Co USD 470M 48M 2024-12
Revvity USD 255.62M 23.46M 2024-12
Tectonic Therapeutic USD 5.3M 962K 2024-09
Viatris USD 882.7M 14.8M 2024-12
Xeris Pharmaceuticals USD 80.28M 35.31M 2024-12



Malin Corporation Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.